Showing results (161-170 of 369) with videos related to
Sort By:
Pageof 37
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate CancerHomer A. Macapinlac, John L. Humm, Timothy Akhurst, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapyTimothy J Judson, Antonia V Bennett, Lauren J Rogak, et al.European Urology|December 17, 2016
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.Endocrinology|March 14, 2009
A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatinEleanor F Need, Howard I Scher, Amelia A Peters, et al.Plos One|September 9, 2010
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancerMayu O Frank, Julia Kaufman, Suyan Tian, et al.Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Novel mutations of epidermal growth factor receptor in localized prostate cancerDiah A Douglas, Hong Zhong, Jae Y Ro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM TrialJimmy L Zhao, Karim Fizazi, Fred Saad, et al.Investigational New Drugs|March 7, 2018
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancerLaura Graham, Kalyan Banda, Alba Torres, et al.The Journal of Urology|September 11, 2019
PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical ProstatectomyNora M Haney, Farzana A Faisal, Jiayun Lu, et al.Pageof 37